bioAffinity Technologies (BIAFW) Cash from Investing Activities (2023 - 2026)
bioAffinity Technologies (BIAFW) reported Cash from Investing Activities of -$5663.0 for Q1 2026, up 88.85% year-over-year from -$2998.7 in Q1 2025, and down 566200.0% quarter-over-quarter from -$1.0 in Q4 2025.
bioAffinity Technologies (BIAFW) Cash from Investing Activities (2023 - 2026) Analysis & Trends
bioAffinity Technologies (BIAFW) has 4 years of Cash from Investing Activities data on file, last reported at -$5663.0 in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$5663.0, up 88.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15445.0 (up 82.54% YoY), and the FY2025 annual result was -$60568.0, up 23.41% from the prior year.
- Cash from Investing Activities retreated to -$5663.0 in Q1 2026 per BIAFW's latest filing, from -$1.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $13442.0 in Q4 2023 and troughed at -$2.2 million in Q3 2023.
- A 4-year average of -$181131.8 and a median of -$9410.0 in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities sank 632.58% in 2024, then surged 138.75% in 2025.
- A 4-year view of Cash from Investing Activities shows it stood at $13442.0 in 2023, then slumped by 100.01% to -$1.0 in 2024, then changed by 0.0% to -$1.0 in 2025, then tumbled by 566200.0% to -$5663.0 in 2026.
- Business Quant data shows BIAFW's Cash from Investing Activities at -$5663.0 in Q1 2026, -$1.0 in Q4 2025, and $3646.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -196.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -32.14 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -31.35 Mn |
| 10 | bioAffinity Technologies | - | - | - | -5,663.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,663.00 |
| Mar 31, 2026 | -5,663.00 |
| Dec 31, 2025 | -1.00 |
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | 3,646.00 |
| Sep 30, 2025 | 3,646.00 |
| Jun 30, 2025 | -13,427.00 |
| Jun 30, 2025 | -13,427.00 |
| Mar 31, 2025 | -50,786.00 |
| Mar 31, 2025 | -50,786.00 |
| Dec 31, 2024 | -1.00 |
| Dec 31, 2024 | -1.00 |
| Sep 30, 2024 | -9,410.00 |
| Sep 30, 2024 | -9,410.00 |
| Jun 30, 2024 | -28,285.00 |
| Jun 30, 2024 | -28,285.00 |
| Mar 31, 2024 | -41,387.00 |
| Mar 31, 2024 | -41,387.00 |
| Dec 31, 2023 | 13,442.00 |
| Dec 31, 2023 | 13,442.00 |